For example, they potently restrain anti-tumor immunity by releasing immunosuppressive factors such as IL-10 and TGF-β1, generating ROS, and expressing immune checkpoint ligands to inhibit the effector function of T cells and NK cells [37,38,39,40]. Here, TGFB1 is linked to neoplasm.